Global Pharma Reach GenScript serves over 200,000 customers in 100+ countries and collaborates with many of the world’s top pharma companies, signaling a strong channel for enterprise collaborations to supply end-to-end biotech building blocks and services.

One-Stop Solutions With a broad portfolio spanning antibody production and characterization, gene synthesis, protein engineering and other building blocks, there is a clear opportunity to upsell bundled, one-stop solutions to existing customers.

Scale and Capacity GenScript operates at a scale with revenues in the mid range and a large global workforce, indicating capacity to pursue larger, multi-year CDMO contracts and rapid ramp-ups for high-demand projects.

Collaboration Network A proven collaboration engine with academia and industry partners—evidenced by COVID-19 antibody work and nasal spray development—creates opportunities for joint development programs and sponsored research partnerships.

Global Footprint A global footprint and enterprise-grade tech stack enable streamlined procurement and scalable supply agreements across regions, making it easier to implement regional partnerships and digital integration.